期刊文献+

卵巢上皮性癌脐转移临床特征分析

Umbilicus metastasis in patients with epithelial ovarian cancer: clinical features of 21 patients
原文传递
导出
摘要 目的 分析卵巢上皮性癌(EOC)脐转移的临床特点,探讨其发生率、诊断、治疗及预后相关因素.方法 回顾性分析1991年1月至2011年1月中山大学肿瘤防治中心收治的EOC患者2642例中经不同取材病理组织学确诊发生脐转移的21例患者的临床病理资料,21例年龄40~66岁.结果 EOC脐转移的发生率为0.79%.未控或复发转移至脐者较初始治疗时已有脐转移者预后差(22比6个月,P<0.01),行姑息或不规则治疗者较采取积极规范手术联合规则化疗者的预后差(21比4个月,P<0.01).脐转移的确诊时间及确诊后的治疗措施是影响预后的独立危险因素.结论 提高对EOC患者发生脐转移诊断的警惕性,综合评估病情及治疗耐受,采取积极的肿瘤细胞减灭术配合规则化疗为主的综合治疗有助于此类患者病情的控制并延长其生存时间. Objective To analyze the clinical features,treatments and prognosis of patients with Sister Mary Joseph's nodule of umbilicus (SMJN) from epithelial ovarian cancer (EOC) patients.Methods Among a total of 2642 pathologically diagnosed EOC cases,21 cases with SMJN were histopathologically diagnosed and had an age range of 40-66 years at Sun Yat-sen University Cancer Center between January 1991 and January 2011.Their clinical data were retrospectively analyzed.Results The incidence of SMJN in EOC was 0.79%.The 1,2 and 5-year survival rates were 61.8%,26.8% and 9.5% respectively.The diagnosis was confirmed via local excision biopsy,fine-needle aspiration biopsy or gross pathological diagnosis.Univariate analysis showed that patients with progressive disease or relapsing with umbilical metastasis after treatment had worse prognosis than those diagnosed at pre-treatment (22 vs 6 months,P 〈 0.01).Patients with suboptional cytoreductive surgery and/or less than 6 circles of chemotherapy or palliative treatment had worse prognosis than those with optional cytoreductive surgery during 6-8 circles of chemotherapy (21 vs 4 months).Multivarivate analysis showed that the time to diagnose and treatment regimen were independent predictors of survival (relative risk =41.28,P 〈 0.01).Conclusion SMJN is a rare manifestation of EOC.Improving the diagnostic vigilance,optimal debulking surgery plus regular chemotherapy and other new individualized postoperative treatments may arrest the progression of EOC and prolong patient survival.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第25期1986-1988,共3页 National Medical Journal of China
基金 广东省科技计划项目
关键词 卵巢肿瘤 肿瘤转移 预后 Ovarian epithelial carcinoma Neoplasm metastasis Prognosis
  • 相关文献

参考文献8

  • 1汤洁,施达仁,杨文涛,陆洪芬,蔡树模.上皮性卵巢癌转移抑制基因KAI1的表达及预后意义[J].中华医学杂志,2005,85(2):115-117. 被引量:5
  • 2赵彦,魏丽惠,等.盆腹腔内恶性肿瘤脐转移三例临床分析[J].中华妇产科杂志,2002,37(12):736-738. 被引量:10
  • 3Palaniappan M, Jose WM, Mehta A, et al. Umbilical metastasis: a case series of four Sister Joseph nodules from four different visceral malignancies. Curr Oncol, 2010, 17:78-81.
  • 4Piura B, Meirovitz M, Bayme M, et al. Sister Mary Joseph's nodule originating from endometrial carcinoma incidentally detected during surgery for an umbilical hernia: a case report. Arch Gynecol Obstet, 2006, 274:385-388.
  • 5Touraud JP, Lentz N, Dutronc Y, et at. Umbilical cutaneous metastasis (or Sister Mary Joseph's nodule) disclosing an ovarian adenocarcinoma. Gynecol Obstet Fertil, 2000, 28:719-721.
  • 6Papalas JA, Selim MA. Metastatic vs primary malignant neoplasms affecting the umbilicus: clinicopathologic features of 77 tumors. Ann Diagn Pathol, 2011, 15:237-242.
  • 7Barrow MV. Metastatic tumors of the umbilicus. J Chronic Dis, 1966, 19:1113-1117.
  • 8Gabriele R, Conte M, Egidi F, et al. Umbilical metastases: current viewpoint. World J Surg Oncol, 2005, 3:13.

二级参考文献19

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1367
  • 2Schindl M, Birner P, Bachtiary B, et al. The impact of expression of the metastasis suppressor gene KAI1 on prognosis in invasive squamous cell cervical cancer. Anticancer Res, 2000,20:4551-4555.
  • 3Adachi M, Taki T, Ieki Y, et al. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res, 1996,56:1751-1755.
  • 4Huang CI, Kohno N, Ogawa E, et al. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol, 1998,153:973-983.
  • 5Takaoka A, Hinoda Y, Satoh S, et al. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene, 1998,16:1443-1453.
  • 6Sho M, Adachi M, Taki T, et al. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer, 1998,79:509-516.
  • 7Houle CD, Ding XY, Foley JF,et al. Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol, 2002,86:69-78.
  • 8Schindl M, Birner P, Breitenecker G, et al. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer. Gynecol Oncol, 2001,83:244-248.
  • 9Liu FS, Dong JT, Chen JT, et al. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Gynecol Oncol, 2000,78:10-15.
  • 10White A, Lamb PW, Barrett JC, et al. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines. Oncogene, 1998,16:3143-3149.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部